Key result
Combined immunosuppression normalizes LVEF to ~55% and resolves symptoms in giant cell myocarditis.
Why the study?
Does combined immunosuppression with corticosteroids and cyclosporine improve left ventricular systolic function and symptoms in a patient with non-fulminant giant cell myocarditis?
Case Report (n=1)
No
Does combined immunosuppression with corticosteroids and cyclosporine improve left ventricular systolic function and symptoms in a patient with non-fulminant giant cell myocarditis?
Giant cell myocarditis can present with rapid decline in left ventricular ejection fraction without overt cardiogenic shock, and early diagnosis via endomyocardial biopsy enables timely combined immunosuppression that can fully restore ventricular function.
Answers are grounded in this paper and cite their sources.
May support combined immunosuppression in non-fulminant giant cell myocarditis; leaves open need for prospective trials.
Giant cell myocarditis is a rare and often fatal disease. The most obvious presentation often described in the literature is one of rapid hemodynamic deterioration due to cardiogenic shock necessitating urgent consideration of mechanical circulatory support and heart transplantation. We present the case of a 60-year-old man whose initial presentation was consistent with myopericarditis but who went on to develop a rapid decline in left ventricular systolic function without overt hemodynamic compromise or dramatic symptomatology. Giant cell myocarditis was confirmed via endomyocardial biopsy. Combined immunosuppression with corticosteroids and calcineurin inhibitor resulted in resolution of symptoms and sustained recovery of left ventricular function one year later. Our case highlights that giant cell myocarditis does not always present with cardiogenic shock and should be considered in the evaluation of new onset cardiomyopathy of uncertain etiology as a timely diagnosis has distinct clinical implications on management and prognosis.
No takes yet. Share an insight, caveat, or question.
Tompkins et al. (2015) conducted a case report in Giant cell myocarditis (n=1). Combined immunosuppression with corticosteroids (intravenous methylprednisolone followed by oral prednisone) and cyclosporine plus guideline-directed heart failure therapy was evaluated on Resolution of heart failure symptoms and recovery of left ventricular ejection fraction. Combined immunosuppression with corticosteroids and cyclosporine resolved heart failure symptoms and restored left ventricular ejection fraction from 25% to 55% in giant cell myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: